Effectivity of GLP-1 in Therapy
Sub-Areas to Effectivity of GLP-1 in Therapy:
Effectivity of Administration Forms
(0)
Degradation by Dipeptidyl Peptidase IV
(7)
GLP-1 Effect After Sufonylurea Therapy
(1)
Food intake and appetite
(2)
(Journal Article): New Therapeutic Strategies for the Treatment of Type 2 Diabetes Mellitus Based on Incretins
Gallwitz B
IN:
Rev Diabetic Stud
2005; 2(2):61-69
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)
ABSTRACT:
Orally ingested glucose leads to a greater insulin response compared to intravenously administered glucose leading to identical postprandial plasma glucose excursions, a phenomenon...
Click HERE for details
(Journal Article): Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus.
Meier JJ, Gallwitz B, Nauck MA
IN:
BioDrugs
2003; 17(2):93-102
Impact Factor(s) of BioDrugs: 1.905 (2004), 2.277 (2003), 0.503 (2001)
ABSTRACT:
Although the insulinotropic actions of gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) have been known for almost 2 decades, the incretin hormones have not...
Click HERE for details
(Journal Article): Contributions a l’etude des variatins physiologiques de la secretion interne du pancreas: relations entre les secretions externe et interne du pancreas.
Zunz E, La Barre J
IN:
Arch Int Physiol
1929; 31:20-44
ABSTRACT:
Not available
Click HERE for details
(Journal Article): Incretin mimetics as emerging treatments for type 2 diabetes.
Joy SV, Rodgers PT, Scates AC
IN:
Ann Pharmacother
2005; 39(1):110-118
Impact Factor(s) of Ann Pharmacother: 1.739 (2004), 1.822 (2003), 1.729 (2001)
ABSTRACT:
OBJECTIVE: To review the physiology, pharmacology, and clinical efficacy of glucagon-like peptide (GLP-1) and the incretin mimetics exenatide and liraglutide in clinical studies. D...
Click HERE for details
(Journal Article): Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives.
Meier JJ, Gallwitz B, Schmidt WE, Nauck MA
IN:
Eur J Pharmacol
2002; 440(2-3):269-279
Impact Factor(s) of Eur J Pharmacol: 2.432 (2004), 2.352 (2003), 2.342 (2002), 2.164 (2001)
ABSTRACT:
After ingestion of carbohydrate- and fat-rich meals, the incretin hormone glucagon-like peptide 1 (GLP-1) is secreted from the L-cells in the distal put into the circulation. Its m...
Click HERE for details
|
| Contribute
to this subject area!
|
|
|
